Jon J. Lyman

Partner

Houston
Willkie Farr & Gallagher LLP
600 Travis Street, Suite 2310
Houston, TX 77002
T 713 510 1770
F 713 510 1799
jlymanwillkie.com

Jon J. Lyman is a partner in the Corporate and Financial Services Department. He has broad experience in international corporate and securities law matters, including representing U.S. and international corporate and investment banking clients in cross-border mergers and acquisitions, securities offerings and trading, private equity transactions and other corporate matters. Jon regularly advises international companies and financial services institutions and their boards on these matters.

Highlights

Jon J. Lyman is a partner in the Corporate and Financial Services Department. He has broad experience in international corporate and securities law matters, including representing U.S. and international corporate and investment banking clients in cross-border mergers and acquisitions, securities offerings and trading, private equity transactions and other corporate matters. Jon regularly advises international companies and financial services institutions and their boards on these matters.

Selected Significant Matters

  • Private equity Fund BC Partners and UK estate agent Foxtons plc on Foxtons £390 million initial public offering on the London Stock Exchange
  • French shipper CMA CGM in its $945 million high yield bond offering listed on the Luxembourg Stock Exchange, and related refinancing of $500 million of existing outstanding Senior Notes
  • Belgo-Dutch Fortis in the €71 billion consortium takeover of ABN AMRO, at the time the largest financial takeover in history
  • French defense and technology company Thales SA in the contested €150 million sale of its electronic payment unit to Hypercom
  • Dutch payment security provider Gemalto N.V. in its €1.8 billion tender offer for and resulting merger with Luxembourg SEC registrant Gemplus International S.A.
  • Israeli Teva Pharmaceutical in its institutional offering of €1 billion of 2.875% senior notes and CHF 450 million of 1.500% senior notes
  • French energy company Toreador Resources in its oil exploration joint venture with Hess Oil France SAS, a subsidiary of Hess Corporation, including $120 million work program
  • Houlihan Lokey as independent financial adviser on the debt restructuring of French entertainment producer/distributor Technicolor (formerly Thomson), including rights issue for a total of €348 million, an issuance of €640 million of bonds redeemable in shares and €300 million of Disposal Proceed Notes bonds
  • Credit Suisse in its €35.9 million share placement for German solar energy company Roth & Rau AG listed on the Frankfurt Stock Exchange
  • Bank syndicate led by Commerzbank and Morgan Stanley on the €460 million rights issue of German private hospital operator RHÖN-KLINKUM AG listed on the Frankfurt Stock Exchange and Munich Exchange
  • German reinsurer Munich Re on the €107 million block trade sale of its equity holding in the UK’s Admiral Group Plc
  • Managing Underwriters Commerzbank and Morgan Stanley on the €47 million capital increase of German real estate company DIC Asset AG listed on the Frankfurt Stock Exchange
  • Toreador Resources in its concurrent $27.2 million SEC-registered public offering of shares listed on Nasdaq and its $31.6 million aggregate principal amount private offering new convertible senior notes and related bond exchange
  • Toreador Resources in the coordinated disposition of its Hungarian and Turkish energy exploratory businesses
  • UK insurer Royal & Sun Alliance Insurance Group plc in its £584million cash tender offer for Danish insurer Codan A/S
  • French pharmaceutical company Sanofi-Aventis in the €183 million sale of its stake in French chemicals company Rhodia in an institutional placement
  • Royal & SunAlliance in the termination and voluntarily delisting of its American Depositary Receipt program from the New York Stock Exchange and termination of its SEC registration
  • Fortis in its €13.5 billion rights offering
  • Total S.A. as controlling shareholder of Sanofi-Synthelabo on Sanofi's €55 billion acquisition of Aventis
  • Swiss Reinsurance Company’s investment in Atradius (formerly Gerling NCM) and Atradius' agreed business combination with Credito y Caucion
  • Underwriters CSFB and Morgan Stanley in the $3.5 billion equity convertible debt and rights offering for Swiss Re
  • Schneider Electric in its €1 billion rights offering